MEDISTIM ASA (MEDI.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:MEDI - NO0010159684 - Common Stock
MEDI.OL Key Statistics, Chart & Performance
The current stock price of MEDI.OL is 250 NOK. In the past month the price decreased by -1.19%. In the past year, price increased by 58.73%.
MEDI.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.19 | 112.62B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.06 | 48.69B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.59 | 23.65B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.75 | 22.45B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.7 | 22.38B | ||
| BIM.PA | BIOMERIEUX | 27.1 | 12.38B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 147.55 | 4.44B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.95 | 3.82B | ||
| DIA.MI | DIASORIN SPA | 18.57 | 3.44B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.47 | 1.27B | ||
| DRW8.DE | DRAEGERWERK AG | 9.3 | 1.13B | ||
| ELN.MI | EL.EN. SPA | 20.16 | 1.04B |
Related stock screener links
About MEDI.OL
Company Profile
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Company Info
MEDISTIM ASA
Okernveien 94
Oslo OSLO NO
Employees: 154
Phone: 4723059660
MEDISTIM ASA / MEDI.OL FAQ
What does MEDISTIM ASA do?
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
What is the stock price of MEDISTIM ASA today?
The current stock price of MEDI.OL is 250 NOK. The price increased by 0.4% in the last trading session.
What is the dividend status of MEDISTIM ASA?
MEDISTIM ASA (MEDI.OL) has a dividend yield of 2.35%. The yearly dividend amount is currently 4.5.
What is the ChartMill technical and fundamental rating of MEDI stock?
MEDI.OL has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the GICS sector and industry of MEDI stock?
MEDISTIM ASA (MEDI.OL) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Is MEDISTIM ASA (MEDI.OL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MEDI.OL.
What is MEDISTIM ASA worth?
MEDISTIM ASA (MEDI.OL) has a market capitalization of 4.58B NOK. This makes MEDI.OL a Mid Cap stock.
MEDI.OL Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL is one of the better performing stocks in the market, outperforming 85.75% of all stocks.
MEDI.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDI.OL. Both the health and profitability get an excellent rating, making MEDI.OL a very profitable company, without any liquidiy or solvency issues.
MEDI.OL Financial Highlights
Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 7.79. The EPS increased by 40.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.3% | ||
| ROA | 24.76% | ||
| ROE | 34.02% | ||
| Debt/Equity | 0.05 |
MEDI.OL Forecast & Estimates
8 analysts have analysed MEDI.OL and the average price target is 265.2 NOK. This implies a price increase of 6.08% is expected in the next year compared to the current price of 250.
For the next year, analysts expect an EPS growth of 16.97% and a revenue growth 17.55% for MEDI.OL